| Factor Information | |
|---|---|
| Data ID | 2541 |
| Factor | EEG as predictor for 18-month BSID |
| Description | EEG=electroencephalography |
| Biomarker | YES |
| Classification | A4 (clinical factor - examination) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | The purpose of this study was to investigate early markers of risk for neurobehavioral compromise in survivors with congenital heart disease (CHD). |
| p Value | 0.044 |
| Conclusion | In fetuses with HLHS, TGA and TOF, abnormal cerebrovascular resistance predicts decreased neonatal EEG left frontal beta power and lower 18-month cognitive development scores. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 607 |
| CHD Type | isolated CHD |
| CHD Subtype | HLHS/TGA/TOF |
| Reference | |
|---|---|
| PMID | 22351034 |
| Year | 2012 |
| Title | Fetal cerebrovascular resistance and neonatal EEG predict 18-month neurodevelopmental outcome in infants with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | fetus and infants | |
| Source | patients' data | |
| Region | New York, America | |
| Method | multivariate linear regression analysis | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | N/A(Treatment) | N/A(Control) |
| Number | N/A | N/A |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | N/A | N/A |
